Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Frontiers in Oncology|January 11, 2020
Transcriptional Silencing of MCL-1 Through Cyclin-Dependent Kinase Inhibition in Acute Myeloid LeukemiaRaoul Tibes, James M BogenbergerRetrovirology|February 2, 2008
Human T Lymphotropic Virus Type 1 protein Tax reduces histone levelsJames M Bogenberger, Paul J LaybournTargeted Oncology|April 23, 2020
Targeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and BeyondJun H Choi, James M Bogenberger, Raoul TibesMolecular Diagnosis & Therapy|October 2, 2012
Current outlook on molecular pathogenesis and treatment of myeloproliferative neoplasmsRaoul Tibes, James M Bogenberger, Kasey L Benson, et al.Expert Opinion on Investigational Drugs|September 21, 2012
JAK2 inhibitors in the treatment of myeloproliferative neoplasmsRaoul Tibes, James M Bogenberger, Holly L Geyer, et al.Faculty Reviews|March 4, 2021
Recent advances in understanding cholangiocarcinomaPedro Luiz Serrano Uson Junior, Mansi Arora, James M Bogenberger, et al.NPJ Precision Oncology|October 11, 2018
Emerging role of precision medicine in biliary tract cancersJames M Bogenberger, Thomas T DeLeon, Mansi Arora, et al.Oncolytic Virotherapy|April 5, 2018
Oncolytic virotherapy in upper gastrointestinal tract cancersRaquel Yokoda, Bolni M Nagalo, Mansi Arora, et al.Journal of Hematology & Oncology|October 21, 2015
The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemiaRaoul Tibes, Aref Al-Kali, Gavin R Oliver, et al.Future Oncology (London, England)|February 21, 2018
Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinomaThomas T DeLeon, Daniel H Ahn, James M Bogenberger, et al.Pageof 2